#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	424	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1048	21.5	0	.	p	.	0	K29T	NONSYN	85	87	AAG	311	313	ACG	28;27;26	A;C;G	28;27;25	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	424	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1048	21.5	0	.	p	.	0	T209S	NONSYN	625	627	ACT	851	853	TCT	20;19;19	T;C;T	20;19;18	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	T879G	SNP	879	879	T	85	85	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	G880A	SNP	880	880	G	86	86	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	A888G	SNP	888	888	A	94	94	G	7	G	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	C897G	SNP	897	897	C	103	103	G	13	G	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	T898C	SNP	898	898	T	104	104	C	15	C	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	G906T	SNP	906	906	G	112	112	T	21	T	21	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	G908A	SNP	908	908	G	114	114	A	21	A	21	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	A918T	SNP	918	918	A	124	124	T	22	T	22	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	A943G	SNP	943	943	A	149	149	G	42	G	42	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	320	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c30.ctg.2	208	15.9	0	.	n	.	0	G991T	SNP	991	991	G	197	197	T	27	T	27	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1441	1443	AGC	42;42;41	A,G;G;C	29,13;42;41	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	1	SNP	p	R234F	1	.	.	700	702	TTC	916	918	TTC	100;103;101	T;T;C	100;102;100	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1216	1218	CGT	102;98;98	C;G;T	101;98;98	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	0	HET	.	.	.	T180C	.	180	180	T	396	396	T	62	T,C	38,19	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	0	HET	.	.	.	T999C	.	999	999	T	1215	1215	T	98	T,C	60,38	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	0	HET	.	.	.	C255T	.	255	255	C	471	471	C	77	C,T	44,32	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1968	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1640	62.7	0	HET	.	.	.	C144T	.	144	144	C	360	360	C	61	C,T	34,27	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	752	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1747	22.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1523	1525	AAA	13;13;13	A;A;A	13;13;13	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	944	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c30.ctg.1	1741	29.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1344	1346	GAA	22;23;22	G;A;A	22;23;22	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	220	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	683	16.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	108	G	83	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	113	T	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	183	G	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	179	C	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	164	C,T	163,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	135	T	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	130	C	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	116	C	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	116	A	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	118	A	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	123	A	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	122	T	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	121	C	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	113	C	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	114	A	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	126	G	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	123	C	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	132	T	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	152	G	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	155	G,A	154,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	157	T	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	144	T	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	132	G	131	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	97	C	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	90	A	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	65	C	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	57	C	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	6	A	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	5	G	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	14	C	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	66	T	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	69	G	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	70	T	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	132	C	132	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2664	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	718	100.6	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	98	C,T	44,30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	650	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1430	24.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	179	181	CGT	15;16;15	C;G;T	14;16;15	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	650	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1430	24.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1022	1024	GGC	32;33;33	G;G;C	32;33;33	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1112	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1974	30.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	190	192	AGC	14;14;17	A;G;C	14;14;17	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1112	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1974	30.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	592	594	CTA	27;28;27	C;T;A	26;27;27	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1112	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1974	30.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1111	1113	CAA	49;51;50	C;A;A	47;51;49	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1112	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1974	30.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1210	1212	GGT	48;48;46	G;G;T	48;48;46	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1112	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1974	30.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1780	1782	GTT	19;17;16	G;T;T	19;16;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	500	PmrE	1167	1167	96.92	PmrE.l6.c17.ctg.1	1506	17.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	652	654	GAA	18;19;19	G;A;A	17;18;18	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	500	PmrE	1167	1167	96.92	PmrE.l6.c17.ctg.1	1506	17.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	832	834	ACC	16;16;16	A;C;C	16;16;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	500	PmrE	1167	1167	96.92	PmrE.l6.c17.ctg.1	1506	17.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	952	954	ACT	11;11;11	A;C;T	10;11;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	500	PmrE	1167	1167	96.92	PmrE.l6.c17.ctg.1	1506	17.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1342	1344	ATC	8;8;9	A;T;C	7;8;9	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	566	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1361	22.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	50	TEM_1+	858	249	99.6	TEM_1+.l15.c4.ctg.1	249	3.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	50	TEM_1+	858	128	97.66	TEM_1+.l15.c4.ctg.2	128	3.5	0	.	p	.	0	V82I	NONSYN	244	246	GTT	117	119	ATT	1;1;1	A;T;T	1;1;1	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1838	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3566	27.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	473	475	ATC	26;25;26	A;T;C	26;25;26	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1838	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3566	27.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2186	2188	AAG	15;15;15	A;A;G	15;15;15	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	776	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1617	25.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	266	268	GTC	9;8;7	G;T;C	9;8;7	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	776	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1617	25.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1007	1009	TGC	44;44;45	T;G;C	44;44;45	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	401	401	T	16	T	16	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	707	709	GAC	35;35;34	G;A;C	34;35;34	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	983	985	TTA	21;20;18	T;T;A	21;20;18	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2060	2062	AAT	30;30;30	A;A;T	30;30;30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2174	2176	AGT	33;32;32	A;G;T	33;32;31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2573	2575	GTG	34;34;33	G;T;G	34;34;33	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	659	1878	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3499	28.6	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3128	3130	AAG	22;24;25	A;A;G	22;24;25	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	460	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1067	23.0	1	SNP	p	R45C	0	.	.	133	135	CGC	325	327	CGC	31;31;32	C;G;C	31;31;32	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	332	acrS	663	663	98.79	acrS.l15.c4.ctg.1	935	18.9	0	.	p	.	0	L34F	NONSYN	100	102	CTC	157	159	TTC	19;19;19	T;T;C	19;19;19	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	332	acrS	663	663	98.79	acrS.l15.c4.ctg.1	935	18.9	0	.	p	.	0	E122G	NONSYN	364	366	GAG	421	423	GGG	17;18;18	G;G;G	17;18;18	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	540	adiY	762	762	99.61	adiY.l15.c17.ctg.1	1138	25.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	576	578	CTT	34;33;33	C;T;T	34;33;33	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1938	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3049	34.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2059	2061	GCA	39;39;40	G;C;A	39;39;40	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1938	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3049	34.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2320	2322	ACC	35;35;37	A;C;C	35;35;37	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1938	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3049	34.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2629	2631	GCC	35;35;32	G;C;C	35;35;32	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	160	162	GCT	2;3;3	G;C;T	2;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	280	282	GAG	5;5;5	G;A;G	5;5;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	316	318	TGC	6;9;9	T;G;C	6;9;9	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	499	501	GTT	21;21;22	G;T;T	21;21;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	649	651	CAC	29;29;28	C;A;C	29;29;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	934	936	ATG	44;43;41	A;T;G	44;43;41	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	978	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2276	22.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1930	1932	CGC	18;19;19	C;G;C	18;19;19	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	372	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1072	17.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	882	884	ACC	10;10;11	A;C;C	10;10;11	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	372	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1072	17.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	894	896	TCG	10;10;10	T;C;G	10;10;10	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	332	baeR	723	723	97.65	baeR.l15.c30.ctg.1	1134	15.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	531	698	baeS	1404	1404	98.79	baeS.l15.c30.ctg.1	1555	23.4	0	.	p	.	0	T9fs	FSHIFT	25	25	A	165	165	A	22	A	22	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	898	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1839	26.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	534	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1104	25.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	548	cysB	975	975	99.38	cysB.l15.c30.ctg.1	1187	24.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	716	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1470	25.3	0	.	p	.	0	W42C	NONSYN	124	126	TGG	325	327	TGT	19;19;19	T;G;T	19;19;19	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	716	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1470	25.3	0	.	p	.	0	I219V	NONSYN	655	657	ATC	856	858	GTC	46;46;47	G;T;C	44;44;46	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1074	emrB	1539	1539	99.81	emrB.l6.c4.ctg.1	1942	29.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	696	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1586	23.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	798	800	AGC	21;21;21	A;G;C	21;21;21	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	26	emrE_1	333	78	96.15	emrE_1.l15.c4.ctg.1	78	8.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	508	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1295	19.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	745	747	AGG	16;15;15	A;G;G	16;15;15	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	508	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1295	19.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1135	1137	GAC	11;11;11	G;A;C	11;11;11	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	364	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1023	19.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	730	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2016	19.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	372	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1029	19.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	410	412	CTG	33;35;34	C;T;G	33;34;33	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	291	293	ATA	11;10;9	A;T;A	11;10;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	303	305	GTA	9;9;9	G;T;A	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	456	458	ACG	21;21;20	A;C;G	21;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	519	521	GAA	27;27;28	G;A;A	27;27;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	558	560	GCT	30;29;26	G;C;T	30;29;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	576	578	GAT	23;23;22	G;A;T	21;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	663	665	TCA	19;20;20	T;C;A	19;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	792	794	CAG	11;12;12	C;A;G	11;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	930	932	GTT	14;15;14	G;T;T	14;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	1021	97.16	evgS.l15.c30.ctg.1	1200	18.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1086	1088	GAT	11;10;10	G;A;T	11;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	196	198	AAA	10;9;9	A;A;A	10;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	931	933	CAT	15;14;14	C;A;T	15;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	985	987	CAT	15;15;16	C;A;T	15;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1003	1005	AGA	21;21;21	A;G;A	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1018	1020	AAT	21;21;21	A;A;T	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1165	1167	TCC	14;14;15	T;C;C	14;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1330	1332	ATT	20;20;19	A;T;T	20;20;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1351	1353	GAT	16;15;16	G;A;T	16;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1465	1467	GTT	33;33;33	G;T;T	33;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1750	1752	CAC	25;27;28	C;A;C	25;27;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1694	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2693	25.2	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	2488	2490	AAC	14;14;15	A;A;C	14;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	518	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1266	21.9	1	SNP	p	P64A	0	.	.	190	192	CCA	387	389	CCA	43;45;43	C;C;A	43;45;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	518	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1266	21.9	1	SNP	p	P64R	0	.	.	190	192	CCA	387	389	CCA	43;45;43	C;C;A	43;45;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	518	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1266	21.9	1	SNP	p	P64H	0	.	.	190	192	CCA	387	389	CCA	43;45;43	C;C;A	43;45;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	518	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1266	21.9	1	SNP	p	P64L	0	.	.	190	192	CCA	387	389	CCA	43;45;43	C;C;A	43;45;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	518	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1266	21.9	1	SNP	p	P64S	0	.	.	190	192	CCA	387	389	CCA	43;45;43	C;C;A	43;45;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	314	gadE	528	528	100.0	gadE.l15.c4.ctg.1	992	17.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	4	6	GAT	5;5;5	G;A;T	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	106	108	ATG	3;3;3	A;T;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	109	111	CCG	3;3;3	C;C;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	I94L	NONSYN	280	282	ATT	124	126	CTT	2;3;3	C,A;T;T	0,1;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	142	144	GAA	2;2;2	G;A;A	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	145	147	TCC	2;2;2	T;C;C	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	148	150	GGG	2;2;2	G;G;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	122	gadW	729	320	92.81	gadW.l6.c30.ctg.1	321	6.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	172	174	AAT	3;4;4	A;A;T	3;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	424	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1151	19.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	357	359	TTA	35;35;34	T;T;A	35;34;34	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	424	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1151	19.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	435	437	ATT	22;22;21	A;T;T	22;22;21	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	424	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1151	19.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	936	938	GGA	12;13;13	G;G;A	12;13;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	424	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1151	19.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	942	944	CCG	12;12;12	C;C;G	12;12;12	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3014	34.6	1	SNP	p	D87G	1	D87G	NONSYN	259	261	GAC	450	452	GGC	35;35;33	G;G;C	34;35;33	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3014	34.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2223	2225	GAA	21;21;21	G;A;A	21;21;21	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3014	34.6	1	SNP	p	S83L	0	.	.	247	249	TCG	438	440	TCG	40;40;39	T;C;G	40;40;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3014	34.6	1	SNP	p	S83I	0	.	.	247	249	TCG	438	440	TCG	40;40;39	T;C;G	40;40;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3014	34.6	1	SNP	p	S83W	0	.	.	247	249	TCG	438	440	TCG	40;40;39	T;C;G	40;40;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136H	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136S	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136I	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136L	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136G	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136C	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1558	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2786	29.8	1	SNP	p	R136E	0	.	.	406	408	CGC	593	595	CGC	24;24;24	C;G;C	24;24;24	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	346	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1058	17.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	447	449	CCG	26;26;27	C;C;G	26;26;27	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	346	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1058	17.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	600	602	GCC	20;20;21	G;C;C	20;20;21	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	662	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1296	27.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	212	214	TCA	23;23;22	T;C;A	23;23;22	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	254	marA	384	384	99.74	marA.l15.c4.ctg.1	794	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	505	507	AGC	13;13;13	A;G;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	607	609	CAT	5;5;5	C;A;T	4;3;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	V45E	0	.	.	133	135	GTG	331	333	GTG	16;16;16	G;T;G	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	I49S	0	.	.	145	147	ATC	343	345	ATC	16;15;15	A;T;C	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	A70T	0	.	.	208	210	GCA	406	408	GCA	14;14;14	G;C;A	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	R73C	0	.	.	217	219	CGT	415	417	CGT	13;13;13	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	R73S	0	.	.	217	219	CGT	415	417	CGT	13;13;13	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	R77C	0	.	.	229	231	CGC	427	429	CGC	14;14;14	C;G;C	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	R77L	0	.	.	229	231	CGC	427	429	CGC	14;14;14	C;G;C	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	L78M	0	.	.	232	234	CTG	430	432	CTG	13;13;12	C;T;G	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	R94H	0	.	.	280	282	CGC	478	480	CGC	6;6;6	C;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	R94S	0	.	.	280	282	CGC	478	480	CGC	6;6;6	C;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	126	marR	435	435	97.7	marR.l15.c30.ctg.1	682	9.3	1	SNP	p	V96E	0	.	.	286	288	GTA	484	486	GTA	6;8;8	G;T;A	6;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	105	107	TTC	1;1;2	T;T;C	1;1;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	192	194	ATC	13;12;11	A;T;C	13;12;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	210	212	GCC	6;6;6	G;C;C	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	213	215	GTG	6;6;7	G;T;G	6;6;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	240	242	GAT	9;9;9	G;A;T	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	261	263	ACC	12;12;13	A;C;C	12;12;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	288	290	TTA	12;12;13	T;T;A	12;12;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	429	431	CAG	18;17;17	C;A;G	18;17;17	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	468	470	GCC	19;18;18	G;C;C	19;18;18	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	573	575	GCG	9;12;12	G;C;G	9;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	L231V	NONSYN	691	693	CTT	777	779	GTT	8;8;9	G;T;T	6;7;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	456	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1509	15.8	0	.	p	.	0	R285fs	FSHIFT	853	853	C	939	939	C	18	C	18	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	538	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1486	19.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	97	97	G	17	G	17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	538	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1486	19.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	154	156	CAG	11;11;11	C;A;G	11;11;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	538	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1486	19.0	0	.	p	.	0	V62I	NONSYN	184	186	GTT	241	243	ATT	20;19;19	A;T;T	19;18;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	538	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1486	19.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	304	306	ATC	12;12;12	A;T;C	12;12;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	538	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1486	19.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	352	354	ATG	7;7;7	A;T;G	7;7;7	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	538	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1486	19.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	445	447	ACC	18;18;15	A;C;C	18;17;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1962	1964	ACC	31;29;30	A;C;C	31;28;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2355	2357	CAA	18;18;18	C;A;A	18;18;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2523	2525	ATT	18;18;18	A;T;T	18;18;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2607	2609	GTT	39;38;38	G;T;T	39;37;38	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2715	2717	GAG	21;20;20	G;A;G	21;20;20	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2943	2945	ATG	24;25;26	A;T;G	24;25;26	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2154	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3499	33.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3078	3080	GAT	23;22;24	G;A;T	23;21;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1778	mdtC	3078	3078	98.7	mdtC.l6.c17.ctg.1	3230	29.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	221	223	ATG	13;13;13	A;T;G	13;13;13	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1778	mdtC	3078	3078	98.7	mdtC.l6.c17.ctg.1	3230	29.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	707	709	ATC	45;44;45	A;T;C	45;44;45	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1778	mdtC	3078	3078	98.7	mdtC.l6.c17.ctg.1	3230	29.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3023	3025	CAC	5;5;5	C;A;C	5;4;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	838	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1877	24.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	173	175	GAA	18;19;18	G;A;A	18;19;18	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	838	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1877	24.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	842	844	GCG	25;23;23	G;C;G	25;22;23	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	838	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1877	24.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1184	1186	ATC	35;34;35	A;T;C	35;34;35	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	838	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1877	24.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1487	1489	TTT	30;31;32	T;T;T	30;31;32	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	888	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1606	29.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2046	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3555	30.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1102	1104	ACC	24;25;27	A;C;C	24;25;27	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2046	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3555	30.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2344	2346	GAC	38;39;37	G;A;C	38;39;37	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	756	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1504	22.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	619	621	ATC	28;27;26	A;T;C	28;27;26	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	756	mdtG	1227	177	99.44	mdtG.l15.c30.ctg.2	184	20.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	5;5;6	G;G;A	5;5;6	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	698	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1616	23.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	640	642	TGT	36;36;35	T;G;T	36;36;35	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	698	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1616	23.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1210	1212	TTG	29;28;27	T;T;G	29;28;27	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	698	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1616	23.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1420	1422	ACG	6;7;7	A;C;G	6;7;7	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	688	mdtL	1176	1176	98.21	mdtL.l6.c30.ctg.1	1633	22.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	765	767	TCC	22;22;21	T;C;C	22;22;21	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	504	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1486	18.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	622	624	ATT	24;24;24	A;T;T	24;24;24	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	168	170	ATG	15;14;13	A;T;G	15;14;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	234	236	ATC	15;15;16	A;T;C	14;15;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	483	485	CGC	24;25;25	C;G;C	22;25;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	849	851	AGC	25;24;26	A;G;C	25;24;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1050	1052	GTG	22;23;23	G;T;G	22;22;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1113	1115	AAC	24;24;25	A;A;C	24;21;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1154	mdtO	2052	2052	97.51	mdtO.l6.c4.ctg.1	2457	25.1	0	.	p	.	0	P330fs	FSHIFT	988	988	C	1125	1125	C	22	C	22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	320	320	T	29	T	29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	503	505	GCG	26;26;29	G;C;G	26;26;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	677	679	ACC	15;16;16	A;C;C	15;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	749	751	CGC	21;20;20	C;G;C	21;20;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	866	868	GCT	20;21;21	G;C;T	20;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	950	952	AAA	13;11;11	A;A;A	13;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	968	970	CGA	11;11;12	C;G;A	11;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1133	1135	GCC	11;10;9	G;C;C	11;10;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1145	1147	GAT	10;10;10	G;A;T	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1596	21.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1562	1564	GCT	5;5;5	G;C;T	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1974	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3863	27.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1496	1498	AAG	17;17;17	A;A;G	17;17;17	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1974	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3863	27.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2573	2575	CTG	32;31;30	C;T;G	32;31;29	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	132	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	318	16.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1344	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2129	33.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1008	1010	AAC	35;35;35	A;A;C	35;34;35	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1344	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2129	33.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1554	1556	ATA	35;36;39	A;T;A	35;35;39	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	904	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1674	28.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1288	1290	GAT	44;44;45	G;A;T	44;44;45	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	904	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1674	28.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1291	1293	CTG	47;47;51	C;T;G	47;47;50	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	313	99.04	nfsA.l15.c4.ctg.1	584	14.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	153	155	TGT	19;19;17	T;G;T	18;19;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	313	99.04	nfsA.l15.c4.ctg.1	584	14.4	1	SNP	p	R15C	0	.	.	43	45	CGC	117	119	CGC	24;24;24	C;G;C	24;24;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	313	99.04	nfsA.l15.c4.ctg.1	584	14.4	1	SNP	p	S33R	0	.	.	97	99	AGC	171	173	AGC	19;19;19	A;G;C	18;19;19	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	419	99.05	nfsA.l15.c4.ctg.2	820	14.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	251	253	ACC	19;19;19	A;C;C	19;19;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	419	99.05	nfsA.l15.c4.ctg.2	820	14.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	461	463	GAC	18;18;18	G;A;C	18;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	419	99.05	nfsA.l15.c4.ctg.2	820	14.4	1	SNP	p	G131D	0	.	.	391	393	GGC	293	295	GGC	28;28;28	G;G;C	28;28;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	419	99.05	nfsA.l15.c4.ctg.2	820	14.4	1	SNP	p	R203C	0	.	.	607	609	CGT	509	511	CGT	22;23;20	C;G;T	21;23;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	394	nfsA	723	419	99.05	nfsA.l15.c4.ctg.2	820	14.4	1	SNP	p	R203L	0	.	.	607	609	CGT	509	511	CGT	22;23;20	C;G;T	21;23;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	842	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1553	29.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1140	1142	GAG	43;42;40	G;A;G	43;42;40	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	842	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1553	29.1	1	SNP	p	G141D	0	.	.	421	423	GGT	627	629	GGT	39;41;41	G;G;T	39;41;41	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	842	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1553	29.1	1	SNP	p	G141E	0	.	.	421	423	GGT	627	629	GGT	39;41;41	G;G;T	39;41;41	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	842	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1553	29.1	1	SNP	p	R154A	0	.	.	460	462	CGT	666	668	CGT	47;44;42	C;G;T	47;44;42	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	842	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1553	29.1	1	SNP	p	R154D	0	.	.	460	462	CGT	666	668	CGT	47;44;42	C;G;T	47;44;42	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1664	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2667	33.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1829	1831	TCG	45;44;46	T;C;G	43;42;46	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1664	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2667	33.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2444	2446	AAC	24;23;23	A;A;C	24;23;23	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1664	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2667	33.5	1	SNP	p	A85T	0	.	.	253	255	GCG	458	460	GCG	39;37;36	G;C;G	37;36;35	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1664	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2667	33.5	1	SNP	p	D111H	0	.	.	331	333	GAT	536	538	GAT	28;29;29	G;A;T	27;28;29	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1664	parC_2	2259	2259	99.29	parC_2.l6.c4.ctg.1	2667	33.5	1	SNP	p	S129P	0	.	.	385	387	TCC	590	592	TCC	35;34;34	T;C;C	33;33;34	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	962	parE_1	1893	1893	97.57	parE_1.l6.c30.ctg.1	2351	21.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1683	1685	GAT	46;46;45	G;A;T	46;45;45	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	918	patA	1380	1380	99.86	patA.l15.c17.ctg.1	1812	27.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1291	1293	GAT	31;32;31	G;A;T	30;32;31	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	V146F	0	.	.	436	438	GTT	639	641	GTT	31;30;27	G;T;T	31;30;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1740	1742	CAG	29;29;28	C;A;G	29;29;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1740	1742	CAG	29;29;28	C;A;G	29;29;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1779	1781	CAC	29;31;33	C;A;C	28;30;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1788	1790	CGT	36;35;33	C;G;T	35;35;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1788	1790	CGT	36;35;33	C;G;T	35;35;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1794	1796	TCC	35;34;34	T;C;C	35;33;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1800	1802	CTC	32;32;31	C;T;C	32;32;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1890	1892	ACC	33;33;33	A;C;C	33;33;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1893	1895	CCT	33;33;33	C;C;T	33;33;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2828	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4550	33.4	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2262	2264	CGT	53;53;52	C;G;T	53;53;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	516	99.81	rrsB+.l15.c17.ctg.1	530	256.3	0	.	n	.	0	C1038T	SNP	1038	1038	C	12	12	T	103	T,C	15,19	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	516	99.81	rrsB+.l15.c17.ctg.1	530	256.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	493	493	A	161	A	160	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	516	99.81	rrsB+.l15.c17.ctg.1	530	256.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	493	493	A	161	A	160	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	516	99.81	rrsB+.l15.c17.ctg.1	530	256.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	493	493	A	161	A	160	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	.	n	.	0	A226G	SNP	226	226	A	345	345	G	302	G	300	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	1157	1157	T	92	T,C	39,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	1	SNP	n	A794G	0	.	.	794	794	A	913	913	A	201	A	197	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	1	SNP	n	A794T	0	.	.	794	794	A	913	913	A	201	A	197	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	1	SNP	n	G926C	0	.	.	926	926	G	1045	1045	G	204	G	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	1	SNP	n	G926T	0	.	.	926	926	G	1045	1045	G	204	G	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	1	SNP	n	G926A	0	.	.	926	926	G	1045	1045	G	204	G	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	G1002A	.	1002	1002	G	1121	1121	G	156	G,A	120,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	A79G	.	79	79	A	198	198	A	223	A,G	150,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	C719T	.	719	719	C	838	838	C	200	C,T	122,78	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	T273A	.	273	273	T	392	392	T	223	T,A	162,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	C183T	.	183	183	C	302	302	C	210	C,T	149,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	T90C	.	90	90	T	209	209	T	205	T,C	140,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	A250T	.	250	250	A	369	369	A	242	A,T	181,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	G474A	.	474	474	G	593	593	G	214	G,A	163,51	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7794	rrsB+	1542	1075	99.81	rrsB+.l15.c17.ctg.3	1194	207.4	0	HET	.	.	.	A253T	.	253	253	A	372	372	A	237	A,T	179,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	410	soxR	465	465	100.0	soxR.l15.c17.ctg.1	833	26.4	1	SNP	p	R20H	0	.	.	58	60	CGC	224	226	CGC	48;46;46	C;G;C	48;46;46	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	410	soxR	465	465	100.0	soxR.l15.c17.ctg.1	833	26.4	1	SNP	p	G121D	0	.	.	361	363	GGT	527	529	GGT	32;33;32	G;G;T	32;33;32	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	232	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	744	16.7	1	SNP	p	A12S	0	.	.	34	36	GCA	226	228	GCA	26;26;26	G;C;A	26;26;24	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1040	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1957	28.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
